The use of extracorporeal membrane oxygenation (ECMO) is associated with better survival rates among select critically ill patients such as those with acute respiratory failure due to COVID-19 1-3 or cardiogenic shock. 4 However, approximately one-half of patients who receive ECMO will die, and severe complications often arise during treatment, including bleeding, ischemia, and neurological problems. 5 Consequently, the functional, cognitive, and mental outcomes after ECMO are extremely important, given that the overall goal of intensive care is survival with good or acceptable health. Yet, the short-and long-term physical and psychosocial outcomes of patients who survive after ECMO treatment are not well documented. 6 Therefore, the study by Fernando and colleagues 7 in this issue of JAMA is of utmost relevance.